HC Wainwright Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX)
HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […]
More Stories
Trump to Ease Tariff Impact on US Carmakers, Lutnick Says
By Aldgra Fredly President Donald Trump will ease some levies imposed on foreign auto parts intended for use in U.S.-made...
Guggenheim Capital LLC Has $246,000 Stock Holdings in Scorpio Tankers Inc. (NYSE:STNG)
Guggenheim Capital LLC trimmed its stake in shares of Scorpio Tankers Inc. (NYSE:STNG – Free Report) by 54.6% during the...
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Aufman Associates Inc
Aufman Associates Inc cut its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 9.6% during the fourth quarter, HoldingsChannel reports. The fund...
Raymond James Financial Inc. Makes New $2.99 Million Investment in Planet Fitness, Inc. (NYSE:PLNT)
Raymond James Financial Inc. purchased a new stake in shares of Planet Fitness, Inc. (NYSE:PLNT – Free Report) in the...
Tsai Capital Corp Sells 328 Shares of Amazon.com, Inc. (NASDAQ:AMZN)
Tsai Capital Corp trimmed its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 1.1% during the fourth quarter, according to...
Amazon.com, Inc. (NASDAQ:AMZN) Stake Lowered by Mechanics Financial Corp
Mechanics Financial Corp decreased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 0.9% during the 4th quarter, according to the company...